FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid for Tumors von Marcus, Leigh, Fashoyin-Aje, Lola A., Donoghue, Martha, Yuan, Mengdie, Rodriguez, Lisa, Gallagher, Pamela S., Philip, Reena, Ghosh, Soma, Theoret, Marc R., Beaver, Julia A., Pazdur, Richard, Lemery, Steven J.

Volltext

Factors associated with disease knowledge and attitude among ambulatory patients with type 2 diabetes - a multicenter study von Aje, Akinniyi A, Fakeye, Titilayo O

Volltext

Spontaneous Object Exploration in a Recessive Gene Knockout Model of Parkinson's Disease: Development and Progression of Object Recognition Memory Deficits in Male Pink1-/- Rats von Pinizzotto, Claudia C, Dreyer, Katherine M, Aje, Oluwagbohunmi A, Caffrey, Ryan M, Madhira, Keertana, Kritzer, Mary F

Volltext

Effect of educational intervention on medication reconciliation practice of hospital pharmacists in a developing country – A non-randomised controlled trial von Aje, Akinniyi A, Showande, Segun J, Adisa, Rasaq, Fakeye, Titilayo O, Olutayo, Oluwakemi A, Adebusoye, Lawrence A, Olowookere, Olufemi O

Volltext

Ending Slavery

Volltext

Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data von Maignan, Kathleen, Fashoyin-Aje, Lola A., Torres, Aracelis Z., Fernandes, Laura L., Gwise, Thomas, Baxi, Shrujal B., Roose, James P., Rivera, Donna R., Shen, Yuan Li, Kluetz, Paul G., Gormley, Nicole J.

Volltext

The On- and Off-Ramps of Oncology Accelerated Approval von Fashoyin-Aje, Lola A., Mehta, Gautam U., Beaver, Julia A., Pazdur, Richard

Volltext

Ending Slavery: The Antislavery Struggle in Perspective von Aje, Lawrence, Raynaud, Claudine

Volltext

Traces and Memories of Slavery in the Atlantic World von Aje, Lawrence, Gachon, Nicolas

Volltext

The Many Faces of Slavery : New Perspectives on Slave Ownership and Experiences in the Americas von Aje, Lawrence, Armstrong, Catherine

Volltext

FDA Approval Summary: Ivosidenib for the Treatment of Patients with Advanced Unresectable or Metastatic, Chemotherapy Refractory Cholangiocarcinoma with an IDH1 Mutation von Casak, Sandra J, Pradhan, Shan, Fashoyin-Aje, Lola A, Ren, Yi, Shen, Yuan-Li, Xu, Yuan, Chow, Edwin Chiu Yuen, Xiong, Ye, Zirklelbach, Jeanne Fourie, Liu, Jiang, Charlab, Rosane, Pierce, William F, Fesenko, Nataliya, Beaver, Julia A, Pazdur, Richard, Kluetz, Paul G, Lemery, Steven J

Volltext

FDA Approval Summary: Tucatinib with Trastuzumab for Advanced Unresectable or Metastatic, Chemotherapy Refractory, HER2-Positive RAS Wild-Type Colorectal Cancer von Casak, Sandra J, Horiba, M Naomi, Yuan, Mengdie, Cheng, Joyce, Lemery, Steven J, Shen, Yuan Li, Fu, Wentao, Moore, Jason N, Li, Yangbing, Bi, Youwei, Auth, Doris, Fesenko, Nataliya, Kluetz, Paul G, Pazdur, Richard, Fashoyin-Aje, Lola A

Volltext

FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement von Patel, Timil H, Marcus, Leigh, Horiba, M Naomi, Donoghue, Martha, Chatterjee, Somak, Mishra-Kalyani, Pallavi S, Schuck, Robert N, Li, Yangbing, Zhang, Xinyuan, Fourie Zirkelbach, Jeanne, Charlab, Rosane, Liu, Jiang, Yang, Yuching, Lemery, Steven J, Pazdur, Richard, Theoret, Marc R, Fashoyin-Aje, Lola A

Volltext

Driving Diversity and Inclusion in Cancer Drug Development - Industry and Regulatory Perspectives, Current Practices, Opportunities, and Challenges von Fashoyin-Aje, Lola A, Tendler, Craig, Lavery, Bea, Ghiorghiu, Serban, Gerald, Brittany, Kalidas, Chitkala, Richie, Nicole, Winson, Kathleen, Warren, Nicholas J H, Tellman, Tristen V, Retzlaff, Jon, Foti, Margaret, Pazdur, Richard

Volltext

Researcher Experience and Comfort With Telemedicine and Remote Patient Monitoring in Cancer Treatment Trials von Lichtenstein, Morgan R L, Levit, Laura A, Schenkel, Caroline, Kirkwood, Kelsey, Fashoyin-Aje, Lola A, Bruinooge, Suanna S, Kelley, Michael J, Mailman, Josh A, Magnuson, Allison, Mirda, Daniel P, Natesan, Divya, Hershman, Dawn L

Volltext

FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements von Gandhy, Shruti U, Casak, Sandra J, Mushti, Sirisha L, Cheng, Joyce, Subramaniam, Sriram, Zhao, Hong, Zhao, Miao, Bi, Youwei, Liu, Guansheng, Fan, Jianghong, Adeniyi, Oluseyi, Charlab, Rosane, Kufrin, Dubravka, Thompson, Matthew D, Jarrell, Kristin, Auth, Doris, Lemery, Steven J, Pazdur, Richard, Kluetz, Paul G, Fashoyin-Aje, Lola A

Volltext

FDA Approval Summary: Ripretinib for Advanced Gastrointestinal Stromal Tumor von Kumar, Vaibhav, Doros, Leslie, Thompson, Margaret, Mushti, Sirisha L, Charlab, Rosane, Spehalski, Elizabeth I, Zhao, Hong, Thompson, Matthew D, Tang, Shenghui, Pazdur, Richard, Lemery, Steven J, Theoret, Marc R, Fashoyin-Aje, Lola A

Volltext

FDA Approval Summary: Nivolumab for the Adjuvant Treatment of Adults with Completely Resected Esophageal/Gastroesophageal Junction Cancer and Residual Pathologic Disease von Horiba, M Naomi, Casak, Sandra J, Mishra-Kalyani, Pallavi S, Roy, Pourab, Beaver, Julia A, Pazdur, Richard, Kluetz, Paul G, Lemery, Steven J, Fashoyin-Aje, Lola A

Volltext

Subgroup Analyses in Oncology Trials: Regulatory Considerations and Case Examples von Amatya, Anup K., Fiero, Mallorie H., Bloomquist, Erik W., Sinha, Arup K., Lemery, Steven J., Singh, Harpreet, Ibrahim, Amna, Donoghue, Martha, Fashoyin-Aje, Lola A., de Claro, R. Angelo, Gormley, Nicole J., Amiri-Kordestani, Laleh, Sridhara, Rajeshwari, Theoret, Marc R., Kluetz, Paul G., Pazdur, Richard, Beaver, Julia A., Tang, Shenghui

Volltext

Analysis of racial and ethnic disparities in multiple myeloma US FDA drug approval trials von Kanapuru, Bindu, Fernandes, Laura L., Fashoyin-Aje, Lola A., Baines, Andrea C., Bhatnagar, Vishal, Ershler, Rachel, Gwise, Thomas, Kluetz, Paul, Pazdur, Richard, Pulte, Elizabeth, Shen, Yuan-Li, Gormley, Nicole

Volltext